← Back to Clinical Trials
Recruiting NCT01659749

NCT01659749 Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT01659749
Status Recruiting
Phase
Sponsor Emory University
Condition Pregnancy
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 1995-06
Primary Completion 2035-07

Eligibility & Interventions

Sex Female only
Min Age 11 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Metabolic camp

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 1995-06 with a primary completion date of 2035-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this project is to study the effectiveness of teaching teens and young women with Phenylketonuria (PKU) or Maple Syrup Urine Disease (MSUD) about their disease and nutrition related issues in a camp environment. It will also look at pregnancy outcome results in women with PKU who attended Metabolic Camp and compare their results to other women with PKU who have not attended the Metabolic Camp.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with PKU or other aminoacidopathy, female, age 11 or older, able to provide informed consent Exclusion Criteria: * Those not fitting the inclusion criteria Inclusion Criteria for healthy controls Individuals eligible to participate in this study must meet all of the following criteria: * Adult camp counselors or staff determined to be in good health. * Not diagnosed with PKU, MSUD or other hereditary metabolic disorder * Willing and able to provide written informed consent * Willing and able to comply with relevant camp guidelines and study procedures

Contact & Investigator

Central Contact

Rani H Singh, PhD RD

✉ rsingh@emory.edu

📞 4047278519

Principal Investigator

Rani H Singh, PhD RD

PRINCIPAL INVESTIGATOR

Emory University

Frequently Asked Questions

Who can join the NCT01659749 clinical trial?

This trial is open to female participants only, aged 11 Years or older, studying Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT01659749 currently recruiting?

Yes, NCT01659749 is actively recruiting participants. Contact the research team at rsingh@emory.edu for enrollment information.

Where is the NCT01659749 trial being conducted?

This trial is being conducted at Atlanta, United States.

Who is sponsoring the NCT01659749 clinical trial?

NCT01659749 is sponsored by Emory University. The principal investigator is Rani H Singh, PhD RD at Emory University. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology